Feds Say Pharma Cos. Can't Win Medicare Drug Price Suit

By Mark Payne · November 30, 2023, 7:23 PM EST

The federal government told a D.C. federal court that it shouldn't issue Merck & Co. Inc.'s summary judgment in its lawsuit challenging the Inflation Reduction Act's Medicare drug price negotiation program,...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

MERCK & CO., INC. v. BECERRA et al

Case Number

1:23-cv-01615

Court

District Of Columbia

Nature of Suit

Civil Rights: Other

Date Filed

June 06, 2023